Acceder

Bibliografías temáticas / Mesothelin targeted cancer immunotherapy / Libros

Siga este enlace para ver otros tipos de publicaciones sobre el tema: Mesothelin targeted cancer immunotherapy.

Libros sobre el tema "Mesothelin targeted cancer immunotherapy"

Autor: Grafiati

Publicado: 11 de marzo de 2023

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte los 30 mejores mejores libros para su investigación sobre el tema "Mesothelin targeted cancer immunotherapy".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Explore libros sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.

1

Yan, Cui, Li Shulin y SpringerLink (Online service), eds. Targeted Cancer Immune Therapy. New York, NY: Springer-Verlag New York, 2009.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

2

N, Syrigos Konstantinos y Harrington Kevin J. 1958-, eds. Targeted therapy for cancer. Oxford: Oxford University Press, 2003.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

3

Anderson, Kenneth C., Razelle Kurzrock y Apostolia-Maria Tsimberidou. Targeted therapy in translational cancer research. Hoboken, New Jersey: John Wiley & Sons, Inc., 2016.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

4

Alharbi, Yousef, Manish S. Patankar y Rebecca J. Whelan. Antibody-Based Therapy for Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0006.

Texto completo

Resumen

With their role in connecting disease-associated antigens to the cellular immune response, antibodies hold considerable promise as therapeutic agents. This chapter discusses three classes of therapeutic antibodies that have been developed for use in ovarian cancer therapy. The first includes antibodies selected against tumor-associated antigens such as MUC16/CA125, mesothelin, epithelial cell adhesion molecule, and folate receptor α‎. Antibodies in the second class target proteins such as CTLA-4 and PD1 that act as immune response checkpoint receptors. The third class of antibodies target secreted factors that promote tumor growth: targets in this class include vascular endothelial growth factor, cytokines, and chemokines. The development of each of these is described. The chapter also discusses the complications presented by soluble antigens, which serve to limit the applicability of antigens (such as MUC16/CA125) that are both cell-surface associated and circulating and the prospects for the combination of antibody-based immunotherapy and chemotherapy.

Los estilos APA, Harvard, Vancouver, ISO, etc.

5

Williams, William Valentine, Karen Anderson, David B. Weiner y Cara Haymaker, eds. Targeted Immunotherapy for Cancer. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88976-074-9.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

6

Li, Shulin, Yan Cui y Joseph Lustgarten. Targeted Cancer Immune Therapy. Springer New York, 2016.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

7

Treating Cancer with Immunotherapy and Targeted Therapy. Mercury Learning & Information, 2019.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

8

Olle, David A. Treating Cancer with Immunotherapy and Targeted Therapy. Mercury Learning & Information, 2022.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

9

Olle, David A. Treating Cancer with Immunotherapy and Targeted Therapy. Mercury Learning & Information, 2022.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

10

Karp, Daniel D., Gerald S. Falchook MD MS y Joann Lim. Handbook of Targeted Cancer Therapy and Immunotherapy. LWW, 2018.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

11

Karp, Daniel D., Joann Lim y Gerald S. Falchook. Handbook of Targeted Cancer Therapy and Immunotherapy. Lippincott Williams & Wilkins, 2022.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

12

Olle, David A. Treating Cancer with Immunotherapy and Targeted Therapy. Mercury Learning & Information, 2022.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

13

Handbook of Targeted Cancer Therapy and Immunotherapy: Gastrointestinal Cancer. Lippincott Williams & Wilkins, 2021.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

14

Targeted therapies in oncology. New York: Informa Healthcare, 2007.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

15

Resistance to Immunotherapeutic Antibodies in Cancer Resistance to Targeted AntiCancer Therapeutics. Springer-Verlag New York Inc., 2013.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

16

Markman, Maurie, Kenneth C. Anderson, Razelle Kurzrock, Apostolia-Maria Tsimberidou y Robert C. Bast. Targeted Therapy in Translational Cancer Research. Wiley & Sons, Incorporated, John, 2015.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

17

Markman, Maurie, Kenneth C. Anderson, Razelle Kurzrock, Bast Robert C. Jr y Apostolia-Maria Tsimberidou. Targeted Therapy in Translational Cancer Research. Wiley & Sons, Incorporated, John, 2015.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

18

Markman, Maurie, Kenneth C. Anderson, Razelle Kurzrock, Bast Robert C. Jr y Apostolia-Maria Tsimberidou. Targeted Therapy in Translational Cancer Research. Wiley & Sons, Limited, John, 2015.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

19

Targeted Therapies in Oncology. CRC Press, 2013.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

20

Giaccone, Giuseppe y Jean-Charles Soria. Targeted Therapies in Oncology. Taylor & Francis Group, 2019.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

21

Giaccone, Giuseppe y Jean-Charles Soria. Targeted Therapies in Oncology. Taylor & Francis Group, 2013.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

22

Giaccone, Giuseppe y Jean-Charles Soria. Targeted Therapies in Oncology. Taylor & Francis Group, 2007.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

23

Giaccone, Giuseppe y Jean-Charles Soria. Targeted Therapies in Oncology. Taylor & Francis Group, 2013.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

24

(Editor), Giuseppe Giaccone y Jean-Charles Soria (Editor), eds. Targeted Therapies in Oncology. Informa Healthcare, 2007.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

25

Jiang, Tao, Zhu Bo, Shengxiang Ren y Tetsuya Mitsudomi, eds. Multi-dimensional Biomarkers and Resistance Mechanism of Targeted Therapy and Immunotherapy in Lung Cancer. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-265-3.

Texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

26

Melanoma Emerging Cancer Therapeutics. Demos Medical Publishing, 2012.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

27

Targeted Radionuclide Tumor Therapy Biological Aspects. Springer, 2008.

Buscar texto completo

Los estilos APA, Harvard, Vancouver, ISO, etc.

28

Aljabali, Alaa A. y Kaushik Pal, eds. Bionanotechnology: Next-Generation Therapeutic Tools. BENTHAM SCIENCE PUBLISHERS, 2022. http://dx.doi.org/10.2174/97898150512781220101.

Texto completo

Resumen

Nanoscale technologies are crucial for the characterization and fabrication of biomaterials that are useful in targeted drug delivery systems. New materials enable the delivery of therapeutic agents to specific tissues and cells in order to treat a range of diseases. Bionanotechnology: Next-Generation Therapeutic Tools provides a quick overview of the use of nanomaterials in modern drug delivery and targeted drug therapy systems. The book starts with an overview of nanomaterial toxicity with subsequent chapters detailing their applications in nanomedicine. Concepts such as immunotherapy, cancer theranostics, molecular imaging, aptamers and viral nanoparticles are highlighted in specific chapters. The simplified presentation along with scientific references makes this book ideal for pharmacology and biomedical engineering scholars and life science readers.

Los estilos APA, Harvard, Vancouver, ISO, etc.

29

Fancourt, Daisy. Fact file 7: Oncology. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780198792079.003.0020.

Texto completo

Resumen

Oncology is a branch of medicine focusing on the prevention, diagnosis, and treatment of cancers; one of the leading causes of death in the world. Early records of cancer have been found in fossils from mummies in ancient Egypt and are discussed in some ancient manuscripts, attesting to the long history of the condition. Oncology teams often encompass medical oncologists (who can specialize in chemotherapy, immunotherapy, hormonal therapy, and targeted therapy), surgical oncologists, radiation oncologists, and doctors with specialities in the organs affected....

Los estilos APA, Harvard, Vancouver, ISO, etc.

30

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne, Gareth Morris-Stiff y Madhumita Bhattacharyya. Gynaecological cancers. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199689842.003.0020_update_001.

Texto completo

Resumen

Genitourinary cancers examines the malignancies arising in the kidney, ureter, bladder, prostate, testis, and penis. Renal cancer has high propensity for systemic spread, largely mediated by overexpression of vascular endothelial growth factor (VEGF). Treatments include surgery, immunotherapy, and targeted therapy. Wilms tumour, a childhood malignancy of the kidney, warrants specialist paediatric oncology management to provide expertise in its unique pathology, staging, and treatment, often with surgery and chemotherapy. Cancer of the bladder and ureters, another tobacco related cancer, may present as either superficial or invasive disease. The former is managed by transurethral resection and intravesical therapy. The latter may require radical surgery, preoperative chemotherapy, or radiotherapy. Prostate cancer, the commonest male cancer, is an androgen dependent malignancy. It has attracted controversy with regards to PSA screening, and potential over treatment with radical prostatectomy. Division into low, intermediate, and high risk disease according to tumour grade, stage, and PSA helps in deciding best treatment, antiandrogen therapy for metastatic disease, radiotherapy and adjuvant hormone therapy for locally advanced disease, either surgery or radiotherapy for early intermediate risk disease, and active monitoring for low risk cases. Testicular cancer divides according to pathology into seminoma, nonseminomatous germ cell tumours (NSGCT), and mixed tumours, the latter two frequently producing tumour markers, alpha-fetoprotein (AFP) and/or human chorionic gonadotrophin (HCG). Stage I disease is managed by inguinal orchidectomy and surveillance or adjuvant chemotherapy. More advanced disease is managed by chemotherapy, with high probability of cure in the majority. Penile cancer, often HPV related, can be excised when it presents early, but delay in presentation may lead to regional and systemic spread with poor prognosis.

Los estilos APA, Harvard, Vancouver, ISO, etc.

Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!